冠状动脉CT血管成像评估冠心病合并新冠感染痰瘀证不同证型脂质斑块特征
天津市滨海新区中医医院
目的 通过冠状动脉计算机断层扫描(CT)血管成像(CTA)检查获取的脂质斑块分布特征与冠心病合并新冠感染患者的不同中医证候特征之间的相关性。方法 选取2023年1月至2024年12月在我院心内科行CTA检查的53例冠心病合并新冠感染患者为观察对象,中医诊断为痰证、瘀证或痰瘀互结证。收集患者病历资料,中医四诊内容及CTA结果,应用统计软件进行统计学分析。结果 在软斑块数量上,痰瘀互结组高于非痰瘀互结组,差异有统计学意义(P<0.05);在钙化性斑块数量上,痰瘀互结型组低于非痰瘀互结型组,差异有统计学意义(P<0.05)。痰瘀互结组、非痰瘀互结组的冠脉狭窄程度比较,差异具有统计学意义(P<0.05)。痰瘀互结证患者的斑块尺寸指标(长度/负荷/体积)和组分指标(钙化/脂质/纤维)显著高于非痰瘀互结,差异有统计学意义(P<0.05)。结论 冠心病合并新冠感染痰瘀证患者接受CTA检查,有助于冠脉狭窄程度的评估,准确判断斑块性质数量,斑块特征定量参数,进而为临床诊治提供数据支持。
Objective To explore the correlation between lipid plaque distribution characteristics obtained from coronary computed tomography angiography(CTA) and different Traditional Chinese Medicine(TCM) syndromes in patients with coronary heart disease complicated by COVID-19 infection. Methods A total of 53 patients with coronary heart disease and COVID-19 infection who underwent coronary CT angiography in the cardiology department of our hospital from January 2023 to December 2024 were enrolled as the study subjects, diagnosed with TCM syndromes of phlegm, stasis, or phlegm-stasis intermingled. Medical records, TCM diagnostic data, and coronary CT angiography results were collected and analyzed using statistical software. Results In terms of soft plaque quantity, the phlegm-stasis intermingled group exhibited significantly higher mean values than the non-phlegm-stasis intermingled group(P<0.05). For calcified plaque quantity, the phlegm-stasis intermingled group showed significantly lower mean values than the nonphlegm-stasis intermingled group(P<0.05). There was a statistically significant difference in the degree of coronary stenosis between the phlegm-stasis intermingled group and the non-phlegm-stasis intermingled group(P<0.05). The plaque size indices(length/load/volume) and component indices(calcification/lipid/fiber) of patients in phlegm-stasis intermingled group were significantly higher than those of non-phlegm-stasis intermingled group, and the difference was statistically significant(P<0.05). Conclusion Coronary CTA examination for patients with coronary heart disease complicated by COVID-19 phlegm-stasis syndrome helps assess the degree of coronary stenosis, accurately determine plaque characteristics and quantity, and quantify plaque features, thereby providing data support for clinical diagnosis and treatment.
引用本文
按标准格式复制,或导出到文献管理软件参考文献
共 15 条- [1]刘明波,何新叶,杨晓红,等.《中国心血管健康与疾病报告2023》要点解读[J].中国全科医学,2025,28(1):20-38.
- [2]Arbab-Zadeh A,Fuster V. Themyth of the“vulnerable plaque”:transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment[J]. J Am Coll Cardiol.2015,65(8):846-855.
- [3]Li W,Wang Y,Huang R,et al. Association of lipid metabolism-related gene promoter methylation with risk of coronary artery disease[J]. Molecular biology reports,2022,49:9373-9378.
- [4]Xia F,Zeng Q,Chen J. Circulating brain-derived neurotrophic factor dysregulation and its linkage with lipid level,stenosis degree,and inflammatory cytokines in coronary heart disease[J]. Journal of clinical laboratory analysis,2022,36(7):e24546.
- [5]Chong Nguyen C,Duboc D,Rainteau D,et al.Circulating bile acids concentration is predictive of coronary artery disease in human[J]. Scientific Reports,2021,11(1):22661.
- [6]Camila de Souza Groia Veloso Ronara,Cruzeiro Maria Gabriela Martins,Dias Bianca Menezes,et al.Assessment of adherence to statin therapy in patients with coronary artery disease:comparison of three selfreporting measures[J]. European journal of hospital pharmacy:science and practice,2023,30(1):24-28.
- [7]张瑞芬,苏和,黄新生,等.不稳定型心绞痛中医诊疗专家共识[J].中医杂志,2022,63(7):695-700.
- [8]孙志宇,刘晓辉.脂蛋白a对急性冠脉综合征患者主要心血管不良事件的预测价值[J].中国临床医学,2025,32(5):820-826.
- [9]Xu P,Cao Y,Ren R,et al. Usefulness of the Systemic Inflammation Response indices and the Systemic Immune Inflammation indices in Predicting Restenosis After Stent Implantation[J]. Journal of inflammation research,2024,17:4941-4955.
- [10]Ridker Paul M,Bhatt Deepak L,Pradhan Aruna D,et al. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy:a collaborative analysis of three randomised trials[J]. The Lancet,2023,401:1293-1301.
- [11]贾东江,张娇阳,李鹏飞,等.急性冠脉综合征患者Lp-PLA-2、sCD40L、ACE2水平变化及临床意义[J].分子诊断与治疗杂志,2025,17(7):1363-1366.
- [12]Chen J,Lin Y,Yin G,et al. Change of ACE2level in serum during development of coronary heart disease[J]. Chinese Journal of Pathophysiology,2017,33(6):1086-1090.
- [13]朱晓霞,董文秀,江宁,等.从痰瘀互结论治冠状动脉微血管病变[J].中国民间疗法,2025,33(17):16-20.
- [14]辛明珠,刘彤.痰瘀互结型不稳定型心绞痛与低密度脂蛋白胆固醇、甘油三酯相关性系统综述[J].实用中医内科杂志,2013,27(24):1-2.
- [15]薛周,龚云燕,袁袁,等.稳定性胸痛患者的高危冠状动脉斑块的CT特征分析[J].中国CT和MRI杂志,2025,23(10):74-76.
| 文章编号 | 2026-04-015(期号内编号) |
|---|---|
| 栏目 | 心脑血管疾病与治疗 |
| 作者 | 刘锐;马雅霞 |
| 作者单位 | 天津市滨海新区中医医院 |
| 基金项目 | 冠状CTA评估不同症候冠心病合并新冠感染患者脂质斑块特征(bhzy202313) |
| 中图分类号 | R259 |
| 卷期页码 | 2026, 2(04): 57-60 |
| 发布时间 | 2026-07-15 |
| 出版时间 | 2026-07-15 |
| 引用信息 | [1]刘锐,马雅霞.冠状动脉CT血管成像评估冠心病合并新冠感染痰瘀证不同证型脂质斑块特征[J].疾病预防与控制,2026,2(04):57-60. |
| 全文地址 | 在知网查看该文(kns.cnki.net) |
| 数据抓取时间 | 2026-09-22T12:14:55 |